Company intelligence / Profile preview

ProBio

Hopewell, New Jersey, United Statesprobiocdmo.com ↗

Ownership: Private
Development stage: Other

Overview

ProBio is a global leader in contract development and manufacturing services for biologic drugs. As a subsidiary of GenScript Biotech Corporation, it offers comprehensive support from drug discovery through commercialization. The company enables biotech and pharmaceutical partners to accelerate development timelines for next-generation therapies—including proteins, mRNA vaccines, viral vectors, antibody-drug conjugates—by providing integrated R&D and GMP-compliant production capabilities. It operates globally with major facilities in New Jersey.

Modalities: BiologicProteinmRNA-based drugsViral vectorAntibody-drug conjugate
Industry: Contract Manufacturing Organization

Partnerships

Engages in licensing/co-development partnerships with biopharma companies globally through flexible risk-sharing models. Specific partner names are not disclosed publicly.

Beyond the preview

Go deeper on ProBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProBio.